000 | 01805 a2200505 4500 | ||
---|---|---|---|
005 | 20250516172907.0 | ||
264 | 0 | _c20140512 | |
008 | 201405s 0 0 eng d | ||
022 | _a1744-7682 | ||
024 | 7 |
_a10.1517/14712598.2013.840285 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNakagomi, Osamu | |
245 | 0 | 0 |
_aIncorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review. _h[electronic resource] |
260 |
_bExpert opinion on biological therapy _cNov 2013 |
||
300 |
_a1613-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aBreast Feeding |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDisease Outbreaks |
650 | 0 | 4 |
_aFeces _xvirology |
650 | 0 | 4 |
_aGastroenteritis _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity, Herd |
650 | 0 | 4 | _aImmunization Schedule |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aIntussusception _xetiology |
650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aRotavirus _ximmunology |
650 | 0 | 4 |
_aRotavirus Infections _xepidemiology |
650 | 0 | 4 |
_aRotavirus Vaccines _xadministration & dosage |
650 | 0 | 4 |
_aState Medicine _xstandards |
650 | 0 | 4 | _aTwin Studies as Topic |
650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
650 | 0 | 4 |
_aVaccines, Attenuated _xadministration & dosage |
700 | 1 | _aIturriza-Gomara, Miren | |
700 | 1 | _aNakagomi, Toyoko | |
700 | 1 | _aCunliffe, Nigel A | |
773 | 0 |
_tExpert opinion on biological therapy _gvol. 13 _gno. 11 _gp. 1613-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/14712598.2013.840285 _zAvailable from publisher's website |
999 |
_c23136295 _d23136295 |